General Information of the Compound
| Compound ID |
CP0426493
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
[1-[[(2R,3S,4R,5R)-5-[6-chloro-4-(cyclopentylamino)pyrazolo[3,4-d]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy]-2-hydroxyethyl]phosphonic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H25ClN5O8P
|
||||||||||||||||||
| Molecular Weight |
493.841
|
||||||||||||||||||
| Canonical SMILES |
OCC(OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ncc2c(NC3CCCC3)nc(Cl)nc12)P(O)(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H25ClN5O8P/c18-17-21-14(20-8-3-1-2-4-8)9-5-19-23(15(9)22-17)16-13(26)12(25)10(31-16)7-30-11(6-24)32(27,28)29/h5,8,10-13,16,24-26H,1-4,6-7H2,(H,20,21,22)(H2,27,28,29)/t10-,11?,12-,13-,16-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DMXMFPHJMRWKEA-BVGIBNHUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound